GoHealth, Inc.GOCONASDAQ

|||

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Analyst Sentiment

Analysts are neutral — opinion is divided on direction.

Consensus Rating

Hold

7 analysts·Limited coverage

Rating Distribution

Strong Buy

00%

Buy

00%

Hold

571%

Sell

229%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 127% higher.

Bear Case

$5.00

+127%

Consensus

$5.00

+127%

Bull Case

$5.00

+127%

Price Range7 analysts

Low

Consensus

High

$5.00

Current Target

Current Price

$2.20

Upside to Target

$2.80

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$-6.63(6 analysts)

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev+84.98%

EPS—

FY2028

Rev+88.86%

EPS—

FY2029

Rev+7.16%

EPS+33.33%

Earnings Surprises

Beat rate:58%(7/12 quarters)

Avg surprise:-13.0%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Nov 26, 2025RBC Capital

GoHealth Inc. (GOCO) PT Lowered to $5 at RBC Capital

Target:$5.00

+73.2%from $2.89

Aug 28, 2025RBC Capital

GoHealth price target raised to $12 from $8 at RBC Capital

Target:$12.00

+135.8%from $5.09

Mar 20, 2024RBC Capital

GoHealth Inc. (GOCO) PT Lowered to $13 at RBC Capital, 'Weaker than expected results driven by lower volumes'

Target:$13.00

+28.0%from $10.16

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance